310 related articles for article (PubMed ID: 28395747)
1. Generation of induced pluripotent stem cells (iPSCs) from a hypertrophic cardiomyopathy patient with the pathogenic variant p.Val698Ala in beta-myosin heavy chain (MYH7) gene.
Ross SB; Fraser ST; Nowak N; Semsarian C
Stem Cell Res; 2017 Apr; 20():88-90. PubMed ID: 28395747
[TBL] [Abstract][Full Text] [Related]
2. Peripheral blood derived induced pluripotent stem cells (iPSCs) from a female with familial hypertrophic cardiomyopathy.
Ross SB; Fraser ST; Bagnall RD; Semsarian C
Stem Cell Res; 2017 Apr; 20():76-79. PubMed ID: 28395744
[TBL] [Abstract][Full Text] [Related]
3. Development of induced pluripotent stem cells from a patient with hypertrophic cardiomyopathy who carries the pathogenic myosin heavy chain 7 mutation p.Arg403Gln.
Holliday M; Ross SB; Lim S; Mangala M; Hill A; Szappanos HC; Hool L; Semsarian C
Stem Cell Res; 2018 Dec; 33():269-273. PubMed ID: 30508693
[TBL] [Abstract][Full Text] [Related]
4. Generation of a hiPSC line ZZUNEUi007-A from a patient with hypertrophic cardiomyopathy caused by mutation in MYH7.
Li X; Liu Y; Liu F; Wang X; Liu M; Du W; Zhao J; Wang M; Hu L; Wang C; Fu W; Dong J; Zhao X
Stem Cell Res; 2020 Mar; 43():101699. PubMed ID: 31931472
[TBL] [Abstract][Full Text] [Related]
5. A heterozygous MYH7 (c. 2156G > A) mutant human induced pluripotent stem cell line (ZZUNEUi020-A) generated from a patient with hypertrophic cardiomyopathy.
Li X; Fu W; Guo G; Liu M; Du W; Zhao J; Liu Y; Wang L; Dong J; Zhao X
Stem Cell Res; 2021 Mar; 51():102158. PubMed ID: 33453578
[TBL] [Abstract][Full Text] [Related]
6. Generation of two clonal iPSC lines, ICGi019-A and ICGi019-B, by reprogramming peripheral blood mononuclear cells of a patient suffering from hypertrophic cardiomyopathy and carrying a heterozygous p.M659I mutation in MYH7.
Dementyeva EV; Kovalenko VR; Zhiven MK; Ustyantseva EI; Kretov EI; Vyatkin YV; Zakian SM
Stem Cell Res; 2020 Jul; 46():101840. PubMed ID: 32422568
[TBL] [Abstract][Full Text] [Related]
7. Generation of an induced pluripotent stem cell line (ZJULLi003-A) from a hypertrophic cardiomyopathy patient carrying MYH7/c.4384G > A mutation.
Zhou J; Sun Y; Wang H; Wang H; Guo F; Chen X; Gong T; Jiang C; Liang P
Stem Cell Res; 2022 Oct; 64():102883. PubMed ID: 35944310
[TBL] [Abstract][Full Text] [Related]
8. Multiplexed Functional Assessments of
Friedman CE; Fayer S; Pendyala S; Chien WM; Loiben A; Tran L; Chao LS; McKinstry A; Ahmed D; Farris SD; Stempien-Otero A; Jonlin EC; Murry CE; Starita LM; Fowler DM; Yang KC
Circ Genom Precis Med; 2024 Apr; 17(2):e004377. PubMed ID: 38362799
[TBL] [Abstract][Full Text] [Related]
9. Generation of three induced pluripotent stem cell lines from hypertrophic cardiomyopathy patients carrying MYH7 mutations.
Cao X; Jahng JWS; Lee C; Zha Y; Wheeler MT; Sallam K; Wu JC
Stem Cell Res; 2021 Aug; 55():102455. PubMed ID: 34352619
[TBL] [Abstract][Full Text] [Related]
10. Generation of an iPSC line (ZZUNEUi016-A) derived from a hypertrophic cardiomyopathy patient with the heterozygote mutation in MYH7 gene.
Guo G; Fu W; Li X; Dong J; Zhao X; Zhang Y
Stem Cell Res; 2021 May; 53():102262. PubMed ID: 33636496
[TBL] [Abstract][Full Text] [Related]
11. Generation of induced pluripotent stem cells (iPSCs) from an infant with catecholaminergic polymorphic ventricular tachycardia carrying the double heterozygous mutations A1855D in RyR2 and Q1362H in SCN10A.
Zhang Y; Li A; Huang CL; Wang G; Wang D
Stem Cell Res; 2019 Aug; 39():101509. PubMed ID: 31382203
[TBL] [Abstract][Full Text] [Related]
12. Enhanced myofilament calcium sensitivity aggravates abnormal calcium handling and diastolic dysfunction in patient-specific induced pluripotent stem cell-derived cardiomyocytes with MYH7 mutation.
Guo G; Wang L; Li X; Fu W; Cao J; Zhang J; Liu Y; Liu M; Wang M; Zhao G; Zhao X; Zhou Y; Niu S; Liu G; Zhang Y; Dong J; Tao H; Zhao X
Cell Calcium; 2024 Jan; 117():102822. PubMed ID: 38101154
[TBL] [Abstract][Full Text] [Related]
13. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
[TBL] [Abstract][Full Text] [Related]
14. Reprogramming of a human induced pluripotent stem cell (iPSC) line from a Parkinson's disease patient with a R1628P variant in the LRRK2 gene.
Ma D; Zhou W; Ng EY; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():45-47. PubMed ID: 28395802
[TBL] [Abstract][Full Text] [Related]
15. Generation of a human induced pluripotent stem cell (iPSC) line carrying the Parkinson's disease linked LRRK2 variant S1647T.
Ma D; Ng SH; Zeng L; Zhao Y; Tan EK
Stem Cell Res; 2017 Jan; 18():54-56. PubMed ID: 28395805
[TBL] [Abstract][Full Text] [Related]
16. Generation of MERRF patient-derived induced pluripotent stem cell line iMERRF-C7.
Liang D; Hu H; Xu T; Wang Y; Hu P; Xu Z
Stem Cell Res; 2016 Nov; 17(3):616-618. PubMed ID: 27934592
[TBL] [Abstract][Full Text] [Related]
17. Generation of induced pluripotent stem cells from peripheral blood CD34+ hematopoietic progenitors of a 31year old healthy woman.
Tangprasittipap A; Jittorntrum B; Wongkummool W; Kitiyanant N; Tubsuwan A
Stem Cell Res; 2017 Apr; 20():91-93. PubMed ID: 28395748
[TBL] [Abstract][Full Text] [Related]
18. Generation of human control iPS cell line CHOPWT10 from healthy adult peripheral blood mononuclear cells.
Maguire JA; Gagne AL; Jobaliya CD; Gandre-Babbe S; Gadue P; French DL
Stem Cell Res; 2016 Mar; 16(2):338-41. PubMed ID: 27345999
[TBL] [Abstract][Full Text] [Related]
19. Generation of an induced pluripotent stem cell line from a hypertrophic cardiomyopathy patient with a pathogenic myosin binding protein C (MYBPC3) p.Arg502Trp mutation.
Holliday M; Ross SB; Lim S; Semsarian C
Stem Cell Res; 2018 Dec; 33():56-59. PubMed ID: 30316040
[TBL] [Abstract][Full Text] [Related]
20. Incomplete-penetrant hypertrophic cardiomyopathy
Lee S; Vander Roest AS; Blair CA; Kao K; Bremner SB; Childers MC; Pathak D; Heinrich P; Lee D; Chirikian O; Mohran SE; Roberts B; Smith JE; Jahng JW; Paik DT; Wu JC; Gunawardane RN; Ruppel KM; Mack DL; Pruitt BL; Regnier M; Wu SM; Spudich JA; Bernstein D
Proc Natl Acad Sci U S A; 2024 May; 121(19):e2318413121. PubMed ID: 38683993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
